Share This

Related Topics News - Drugs

     
 < Previous page   Detail   |   Print    Next page > 
     
《大行》瑞銀上調石藥目標價至10.1元 首季業績勝預期
2024-05-28T  
《大行》大和上調石藥目標價至8元 首季業績勝預期
2024-05-28T  
《大行》中銀國際上調石藥目標價至10.2元 成藥銷售強勁首季業績勝預期
2024-05-28T  
石四藥用於癌症化療和放射治療引起噁心嘔吐注射液獲生產註冊批件
2024-05-27T  
四環醫藥撤回軒竹生物上交所上市申請
2024-05-26T  
生物醫藥股下跌 康方生物急挫39% 百濟神州跌8%
2024-05-24T  
國藥控股完成發行30億人幣公司債
2024-05-24T  
金斯瑞生物科技附屬傳奇生物將於歐美醫學年會公布臨開發資料
2024-05-24T  
石四藥旗下原料藥登記獲批
2024-05-22T  
山東新華製藥治療抑鬱症藥取得藥品註冊證書
2024-05-22T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.